The Cytotoxicity of Cysteinylcatechols and Related Compounds to Human Melanoma Cells In Vitro  by Yamada, Ichiro et al.
The Cytotoxicity of Cysteinylcatechols and Related 
Compounds to Human Melanoma Cells In Vitro 
Ichiro Yam ada, M.D. , Sachik o Scki, M.D ., Osamu Matsubara , M .D. , Shosukc Ito, Ph .D., 
Soji Suzuki , M .D., and Tsutomu Kasuga, M.D . 
Sccond Dq)art ll1 clH of Pathology and Departmcnt 01 rl.ad iology. School of Medic ine. Tokyo Med ical and Denta l Uni versity (IY . 
SS. OM. SS. TK), Tokyo. and School o f Hygienc. Flijita-Gakuen I-Icalth Uni vcrsiry (S I). Ai chi . japan 
L-3,4-Dih ydroxy phenyl alanine (L-dopa) and its structura l 
analogs are known to be po tentl y cy totoxic to melan o m a 
cell s. We examined the effects of cys tein ylcatecho ls and 
related co mpo unds, w hi ch were newly synth es ized as cys-
teiny l derivat ives o f L-dopa, o n the g rowth o f hum an mel-
ano m a cell s in vitro, and th eir ac tio ns we re co mpared w ith 
those of L-dopa. 4-S- and 3-S-Cystein y lcatechols showed 
sig nifi ca ntl y m o re po tent cy to tox icity to melano m a cell s 
than did L-dopa , and 2- S-cyste in ylh yd roquin o ne was nex t 
P o lyphcnoli c in term cdiates in the fo rm at io n of melanin from tyrosine arc known to be po tenti all y cyto tox ic agents /1 -3 /. Wi ck et al showed that L-3,4-dih yd rox-yp henylalanin e (L-do pa) is select ivel y tox ic to mel a-no m a ce lls in vitro f4 / and that its chemi cal ana logs also 
ex hibit antitum o r act ivit y in experimental tum o r syste m s /5-91. 
Recentl y . Ito . et al fl O/ fo un d that 5-S-cyste in y l-3,4-di -
hyd roxyphenylalanine (5- S-cystein y ldo pa), an interm ed iate in thc 
m etabo li c pathway fro l11 L-dopa to pheo m clanin , is mu ch m o re 
cy totox ic than L- dopa itself and suggested that the catecho ls w ith 
the cys te in yl g ro up show a potent antitum o r activity . In an at-
tempt to obta in m ore e ffcctive agents, we have new ly sy nthes ized 
var ious cysteinyl derivatives as st ru ctural ana logues of L-do pa and 
studied the effects of these dru gs o n the g rowth of cu ltured hUl11 an 
m ali g nan t melano m a ce lls. 
MAT ER IALS AND M ET H ODS 
Chemicals T he 7 new dru gs were sy nthes ized by o ne of the 
au tho rs (S. I. ); the deta il s o f the che mi ca l sy nth es is h;lVc bem 
reported elscw he re /11/ . T he dru gs co uld be class ified in to 2 
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Abbreviat ions: 
I.-dopa: L-3.4-d ih ydroxy phenylabnilll' 
IC,,,: SO'y-, growth inhibition concelltration 
2-S-C H: 2-S-cys teinylh ydroquinone 
2-S-C I<: 2-S-cysteinylreso rcin ol 
3-S-CC: 3-S-cystcin yJcatechol 
3-S-C-S-M C: 3-S-cys tein yl-5- lll eth ylGltechul 
4-S-CA 1': 4-S-cystca lllill ylphcll ol 
4-S-C P: 4-S-cysteiny lphcnol 
4-S-CC: 4-S-cys tein ylca techol 
to the ca techo ls in po ten cy. The mechani sm of act ion m ay 
invo lve interac tio n w ith the m elan ocy te-specifi c enzym.e, 
tyros in ase, fo r wh ich th e cys tein ylcatecho ls could beco m e 
a better substrate than L-dopa itself. 4-S-Cysteaminyl-
phen ol was alm ost co mparable to L- dopa in cy totox icity, 
suggesting that thi s phenol mig ht be oxidized to the cor-
respondin g ca techol by tyrosinase within the m elanoma 
cell s. J Invest Derrnafo/ 88:538-540, J 987 
g roups o n the basis of che mi ca l stru ctures; o ne was the dipheno l 
group , w hi ch contained 2 hydroxyl g roups as side chains . Th.is 
g roup included 4-S-cystei ny lcatechol (4-S-CC) , 3-S-cys tein y l-
catecho l. H C I. H 20 (3-S-CC), 3-S-cyste in y l-5-methylcatecho l (3-
S- C -5-M C), 2- S- cystein ylh ydroguin o ne (2-S-CH), and 2-S- cys-
tei ny lreso rcin o l (2-S-C R) . 4-S-Cystein ylca techo l had the chem-
ica l st ru cture in w hi ch o nl y a sulfur ato m was introdu ced into a 
m o lecule of L-dopa . T he o the r g ro up was ph eno l, and it included 
4-S-cyste:1minylpheno l (4-S-CAP) and 4-S-cystein y lph enol (4-S-
C Pl. L-Dopa was purchased fro m Sig m a C he mica l Co. (St. Lo uis, 
Mi sso uri) . All the dru g so lu t io ns were fres hl y prepared in Ham 's 
F-l0 m cdium (G ibco Labo rato ries, G rand Island, N ew York) just 
bcfo rc usc at the beg innin g o f each ex perim ent. 
Cells T he human malig nant m elano m a cell lin e (HMV-I) used 
in this study was estab li shed from a black-brown mali gnant m el-
ano ma in the vagina l wa ll of a 65-yea r-old wo m an [1 2]. The 
HMV-I ce ll s were m aintain cd in I-la m 's F-l0 m edium supple-
m cnted with 10°;(, calf scrum (Flow Labo rato ries In c., Rockv ille, 
Mary land), penicillin (100 U / ml) , and streptom ycin (100 J.Lg/ml ), 
and in cubated in a humidifi ed atm ospherc of 95% air and 5% 
CO2 at 3rc. 
Effects of the Drugs 011 Cell Growth Cell s ( I X 105) were 
plated in 35-mm plasti c dishes (tissue culture Petri di sh ; Falco n). 
After 4H h of in cubati o n , the m edium was repla ced w ith fresh 
culture m ed ium containin g th e desired concentratio ns o f each 
dru g. T he range o f dru g concentrations was from 2 J.Lg/ml to 2 .2 
mg/ llll , although it va ri ed dependin g o n e ffects o f the drugs. 
Dup li cate cultures we re set up at each o f the concen trat io ns. For 
each drug, assays we re perfo rm ed at lea st 3 tim es. After 48 h of 
dru g ex pos ure at 37°C, th e m edium was rem oved and the cells 
were trypsi ni zed. The III 1111 bel' of ce ll s per d ish , assessed by trypan 
blue cx clusio n , was determin cd mi crosco pi call y with a hemo-
cyto m eter. Und er th e ex perimental conditi o ns prov ided , th e av-
e rage do ublin g tim c of contro l ce ll s was 21.0 h. 
T he avera gc numbe r of ce ll s in each t reated culture was ex-
pressed as a percen ta ge o f the average num ber of cells in the 
co ntro l cul tures w ith o ut dru gs . The IC su value was defi ned as the 
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dosc effective in inhibiting 50% of the cell population growth 
after 48 h of exposure to the drug. T he ICs" va lue was determined 
from a linear reg ress ion w ith the aid of a computer. T he sign if-
icance of d iffe rence of response to different dru gs was based on 
Stu dcnt 's (-test . 
RESULTS 
Figure 1 shows the dose-response curve of eKh drug to HMV-
I hu rn an Ill elano ma ce lls after 48 h of drug ex pos ure, and the ICs" 
valu e of each d ru g was summari zed in Table I. 
T h e IC so value of3-S-CC was 12.6 p,g/ ml and that of 4- S-CC, 
15.7 p,g/ml ; the 2 cystein ylcatecho ls showed the most potent 
grovvth-inhibitory effect of the dru gs exa mined in this stud y. T he 
leso va lue of I.-dopa exa mined fo r the purpose of co mparison 
was 22.5 p,g/ml , and 3-S- CC and 4- S-CC had a significantl y 
potent effect on HMV-I cell s compared with L-dopa (p < 0.05 
for each drug). 
2-S-Cystein y lhydroq uin one had an IC so value of 25.4 p,g/ml. 
T his was next to the 2 cysteinylcatechols in potency and was 
com.parable to I.-dopa 0) > 0.(5). However, the IC so va lue of 3-
S-C-5-MC was 29.4 p,g/m l , about 2 times larger than that o f 3-
S-CC 0J < 0.05), and this in dicated that the introduction of a 
meth yl group in the C-5 position ofJ-S- C resulted in a decrease 
of tbe effectiveness. 2-S-Cystein ylresorcino l had an IC so value of 
244 .3 p,g/m l and was the least effective of the diphenols. 
With respect to the pheno ls, the IC so va lue of 4-S-CAP was 
24.1 p,g/m l, and this phenol showed a g rowth-inhibi to ry effect 
cOlJlpara ble to L-dopa, a ca techoli c compo und 0) > 0.05) . H ow-
ever, 4-S-CP had an IC so value of952.2 p,g/ ml and was the least 
effective. 
D ISCUSSION 
3-S-Cystein ylcatechol and 4-S-CC showed the most potent growth-
inhibitory effect of the drugs exa mined in thi s stud y and we re 
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Table I. Fifty Percent G rowth Inhi biti on Concentration 
(IC su) of the Drugs to HMV-I Human Melanoma Cells 
ICsu ICs" Ratio Significance 
Drug (J.1g/ ml)·' (I.-dopa/drug) (p va lue)I' 
3-S-CC 12.6 1.79 < 0.05 
4-S-CC \5.7 1. 43 < 0.05 
L-Dopa 22.5 1.00 
4-S-CAP 24. 1 0.93 > 0.05 
2-S- H 25.4 0.89 > 0.05 
3-S-C-S-MC 29.4 0.77 < 0.05 
2-S-CH 244.3 0.09 < 0.0 1 
4-5- P 952.2 0.02 < 0.01 
"Each ICslI va llie is an average of values fro m 3-5 scp:t r:ltc experi ment s. 
I'T he signi fi cance vns c:llcubtcd between L-dopa ;l1ld o ther dru gs as described in 
}\ifafl'rifl/s ami JVlcr/wds . 
era l, 2 mechanisms have been postulated concerning the cy to-
toxicity of catechols [6,7, 13]; one is that catechols are converted 
to the correspo nding benzoq uinones, and the quinones produce 
dama ge to th e cell s through inactivation of sulfhydryl enzy mes, 
such as D NA po lymerase cr, which playa centra l role in the cell 
growth. T he other mechanism is that the catechols are auto-
oxid ized to produce cytotoxic hydrogen peroxide, superox.ide, 
and hydroxy l radicals. It is well known that , in melanoma cells, 
the conversio n of L-dopa and its analogs to quinones can be me-
diated by the specifi c enzy me tyrosinase [14], and the quinones 
have been demonstrated to have a marked affi ni ty for th e sulfhy-
dry l enzy mes [2] and form cova lent binding w ith th e sulfh yd ryl 
gro ups 11 5]. 
T he reason w hy the cysteillylcatecho ls are more cytotoxic to 
melanoma cells than L-dopa is yet to be studied . However, it 
could be ascribed to the presence of a sulfur ato m in their m ol-
ecule. The sul fur atom call in crease lipophi lic properties and pro-
0.1 1 
CONCENTRA TION (mg/ml) 
Figure 1. Effects of the drugs on the growth of I-I M V -I human Illclanoma cell s. Thc cells were exposcd to the different drug conccntrations in the 
conditions described in Mr/l cri(/Is (/wl Metliods. The res ul ts were expressed as the perccntage of control cell growth aftcr 48 h of drug exposure. Va lues 
represent mean ± 5E of 3-5 determinations. Opell tri(/ligles, 3-5- C; closed circles, 4-5-CC; OpCII circles, L-dopa; closed Sq"afCS, 4-5-CAP; opell sqrwrcs, 
2-S-CH ; closed (rial/s ics, 3-5-C-5-MC; six-sided stnrs, 2-S-CR; jille-sidcd S((/rS, 4-5- P. 
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mote effi cicnt uptake into th e cells [11]. In addition . our ongoing 
stud y indica tcd th at the cysteinylcatccho ls could beco me a better 
substratc fo r tyrosinase prepared from mushroom and mam-
malian mela noma cells than L-dopa. This may bc due to the 
elcctron-donatin g rcsonance effcct o f the sulfur atom. which can 
incrcasc thc affinit y fo r tyrosinasc [1 6]. 
2-S-Cystcin ylh ydroquinonc w as sccond to the catcchols in cy-
to toxicity. H ydroquinone itself has becn known to have selectivc 
toxicity against mclanocytes in vivo and is used clinically as a 
depigmcnting agcnt [17. 18]. C havin ct al [1 9] showcd that hy-
droquinonc signifi cantly prolongs thc survival o f melanoma-bearing 
micc. Rcccntl y. Pcnney et al [201 sugges ted th at the cytotoxicity 
of hydroquinonc to melano ma cell s may be via its oxidation by 
ty rosinasc . T hereforc. it is possible th at the cy to toxicity of 2-S-
C H to melanoma cells. comparable to L-dopa in po tcncy. is also 
duc to its tyrosinasc-mcdiated oxidation. 2-S-Cystcinylresorcinol 
was thc Icast effccti vc among the diphenols. and thi s may be duc 
to thc fac t that rcsorcinol is chemica lly unablc to undcrgo oxi-
dation to a quinonc [21]. 
O ur rcsults dcm onstrate that 4-S-C AP. a phcnol . is much more 
cyto toxic to melanoma cells than is 4-S-CP . ano th er phenol . and 
4-S-C AP is almost comparable to L-dopa. a catecho l. in potency. 
The rcason for this is no t c1car at present. How evcr. removal o f 
the ca rboxyl group from 4-S-C P can incrcase the lipophilic prop-
erties. and thcre may be effi cient uptakc into th e cells [11]. It is 
possible that 4-S-C AP incorpo ratcd into melanoma cells is oxi-
dizcd by tyrosinase to produ ce the corresponding catecho l. which 
in turn cxcrts a po tcnt cytotoxic effcct comparable to L-dopa. 
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